Vir Biotechnology, Inc. (VIR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:49AM EDT. Market open.
| Previous close | 8.74 |
| Open | 8.91 |
| Bid | 9.07 x 400 |
| Ask | 9.14 x 200 |
| Day's range | 8.74 - 9.14 |
| 52-week range | 7.61 - 27.48 |
| Volume | |
| Avg. volume | 1,034,881 |
| Market cap | 1.237B |
| Beta (5Y monthly) | 0.41 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.59 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 32.29 |
Business WireVir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024
SAN FRANCISCO, April 30, 2024--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled to participate in a fireside chat at the BofA Securities Healthcare Conference 2024 on Tuesday, May 14, at 4:20 p.m. PT / 7:20 p.m. ET.
Simply Wall St.With 53% ownership, Vir Biotechnology, Inc. (NASDAQ:VIR) boasts of strong institutional backing
Key Insights Institutions' substantial holdings in Vir Biotechnology implies that they have significant influence over...
ZacksWhat Makes Vir Biotechnology (VIR) a New Buy Stock
Vir Biotechnology (VIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
© 2024 Yahoo. All rights reserved.